Amia Capital LLP Arvinas, Inc. Transaction History

Amia Capital LLP

  • $126 Million
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$22.99 - $36.34 $160,332 - $253,435
-6,974 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$29.88 - $56.74 $114,769 - $217,938
-3,841 Reduced 35.52%
6,974 $234,000
Q1 2020

May 15, 2020
BUY
$33.0 - $54.5 $356,895 - $589,417
10,815 New
10,815 $436,000

Others Institutions Holding ARVN

# of Institutions
224
Shares Held
68.7M
Call Options Held
166K
Put Options Held
31.3K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.33B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Amia Capital LLP Portfolio

Follow Amia Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Amia Capital LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email